Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6651–6700 of 18646
Harte Hanks, Inc. (the “Company”) announced today that David Garrison who has been serving as Interim Chief Financial Officer was appointed to role of permanent Chief Financial Officer ("CFO") of the Company, effective as of January 29, 2024.
On January 16, 2024, SEI Investments Company (the “Company”) entered into an agreement with Sean Denham, 51, to begin employment with the Company on March 18, 2024 and serve as the Company’s Chief Financial Officer effective upon the date following the current Chief Financial Officer Dennis McGonigle’s resignation in connection with his previously announced retirement.
On January 16, 2024, SEI Investments Company (the “Company”) entered into an agreement with Sean Denham, 51, to begin employment with the Company on March 18, 2024 and serve as the Company’s Chief Financial Officer effective upon the date following the current Chief Financial Officer Dennis McGonigle’s resignation in connection with his previously announced retirement.
designated Blair C. Jackson, Executive Vice President, Chief Operating Officer of Alkermes, Inc., a wholly-owned subsidiary of the Company, as the Company's interim principal financial officer
On January 30, 2024, Gary Millerchip, Senior Vice President and Chief Financial Officer of The Kroger Co. (“Kroger”), informed Kroger of his decision to step down from his role at Kroger to assume an executive role at another public company.
Todd Foley, Group Vice President, Corporate Controller and Chief Accounting Officer of Kroger, has been appointed interim Chief Financial Officer, effective February 5, 2024.
appointed Ms. Laura Coffey as the Company’s Chief Financial Officer, effective as of February 5, 2024
Ms. Coffey succeeds Ms. Andrea K. Tarbox, who served as the Company’s interim Chief Financial Officer
Thomas E. O’Hern, the Company’s current Chief Executive Officer, will be retiring effective as of February 29, 2024
On February 5, 2024, The Macerich Company (the “Company”) announced that Jackson Hsieh will be appointed to the role of Chief Executive Officer and President, effective as of March 1, 2024.
on February 4, 2024, the Company appointed David Rockvam as Executive Vice President and Chief Financial Officer of the Company, effective immediately.
Mr. Rockvam will succeed Patrick Brickley whose last day of employment will be March 15, 2024
On February 1, 2024, the Board of Directors of Madison Square Garden Entertainment Corp. (the “Company”) appointed Michael Grau, 58, as Executive Vice President and Chief Financial Officer effective as of April 1, 2024.
Michael Rhodes has been appointed as Chief Executive Officer and Secretary of the Company.
On February 2, 2024, the Board of Directors of Chegg, Inc. (the “Company”) appointed David Longo, 56, as the Company’s Chief Financial Officer, Principal Financial Officer, and Treasurer, effective February 21, 2024, to serve until his successor is duly elected and qualified or until the earlier of his death, resignation or removal.
Mr. Longo is replacing Andrew Brown, who notified the Company of his retirement in October 2023, as previously disclosed in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on October 30, 2023.
the Board has determined that Mr. Confer can and shall act alone in covering when Mr. Varner is unavailable.
On January 31, 2024, Mary Riskey notified Two Harbors Investment Corp. (the "Company") of her intention to retire from her position as Vice President and Chief Financial Officer of the Company, effective no later than August 1, 2024 (the "Effective Date").
Joe D. Staggs, the Company’s President and Chief Executive Officer, will assume the responsibilities of principal financial and accounting officer on an interim basis.
On January 30, 2024, Yvette Heinrichson, the Chief Financial Officer and principal financial and accounting officer of SWK Holdings Corporation (the “Company”), notified the Company of her decision to resign, effective February 13, 2024
On February 4, 2024, in connection with Douglas Manion’s departure from the Company as the Company’s Chief Executive Officer and President, the Company and Dr. Manion entered into a Separation Agreement
in connection with the departure of Dr. Manion, on January 15, 2024, the Board appointed Neal Walker as the Company’s Interim Chief Executive Officer and President, effective January 17, 2024.
On January 15, 2024, the Company and Douglas Manion mutually agreed that Dr. Manion will step down as the Company’s Chief Executive Officer and President and resign from the Board of Directors (the “ Board ”), effective January 16, 2024.
William A. Kozy will step down from his current position as Interim Chief Executive Officer of the Company on March 1, 2024 but will remain the Chair of the Board.
the Company’s Board of Directors (the “Board”) appointed Vladimir A. Makatsaria as Chief Executive Officer of the Company, effective as of March 1, 2024
On January 30, 2024, the Company entered into an employment agreement with John Kim pursuant to which Mr. Kim agreed to serve as the Company’s chief executive officer and president, effective February 3, 2024.
On December 29, 2023, Richard Brounstein, informed the Company of his plans to retire from his position (the “ Retirement ”) as Chief Financial Officer of HeartBeam, Inc. (the “ Company ” or " HeartBeam ") effective as of February 1, 2024.
Effective February 12, 2024, Christopher Craig, age 50, the Company's Senior Vice President, Controller and Chief Accounting Officer (and principal accounting officer), will assume the role of Chief Financial Officer (and principal financial officer) on an interim basis, and also continue to serve in his current role, until such time as a new Chief Financial Officer (and principal financial officer) is appointed.
elected Tony Spring, age 58, Chief Executive Officer and Chairman of the Board-Elect of the Company, effective February 4, 2024
On January 30, 2024, Samuel J. Reich, age 49, the Executive Chairman of the Board of Directors (the “Board”) of SAB Biotherapeutics, Inc. (the “Company”), was appointed Chief Executive Officer of the Company, effective immediately.
On January 29, 2024, Ching W. Jaw, Senior Vice President & Chief Financial Officer, informed Cytokinetics, Incorporated (the "Company") that he would be resigning his office and employment with the Company effective February 23, 2024.
On January 30, 2024, the Board appointed Cherine Pottinger-Harris as the Company's Principal Accounting Officer and interim Chief Financial Officer.
On January 22, 2024, Natalia Vakhitova notified the Board of Directors of Evome Medical Technologies Inc. (the "Company") of her intention to resign as the Company's Principal Accounting Officer and Chief Financial Officer effective on January 22, 2024.
The Company terminated the employment of Mark Doerr, the Company’s President and Chief Executive Officer, and Ramona Seabaugh, the Company’s Chief Financial Officer, Treasurer and Secretary, effective on February 2, 2024
The Company terminated the employment of Mark Doerr, the Company’s President and Chief Executive Officer, and Ramona Seabaugh, the Company’s Chief Financial Officer, Treasurer and Secretary, effective on February 2, 2024
On January 31, 2024, Joseph Marnikovic notified the board of directors (the “Board”) of American Strategic Investment Co. (the “Company”) that he intends to retire and therefore resign from his position as Chief Financial Officer and Treasurer of the Company
On February 2, 2024, the Board appointed Mr. Michael LeSanto, the Company’s Chief Accounting Officer, as the Chief Financial Officer (Principal Accounting Officer and Principal Financial Officer) and Treasurer of the Company
On January 29, 2024, Greenbrook TMS Inc. (the “ Company ”) announced that the Company’s board of directors appointed Mr. Peter Willett, age 34, as the Company’s full-time Chief Financial Officer, effective immediately.
On December 28, 2023, Anthony Rimac, the Chief Financial Officer of Sagimet Biosciences Inc. (the “ Company ”) provided notice of his intent to resign effective January 31, 2024.
On January 31, 2024, the board of directors (the “ Board ”) of the Company appointed Joseph Oriti as Interim Principal Financial Officer and Interim Principal Accounting Officer, effective as of February 1, 2024 (the “ Effective Date ”).
the Company announced the appointment of Eric J. Guerin as the Company’s Chief Financial Officer effective January 15, 2024.
On January 29, 2024, RGC Resources, Inc. ("Resources" or the "Company") appointed Timothy J. Mulvaney, the current Interim Chief Financial Officer and Treasurer, as Vice President, Treasurer and Chief Financial Officer of Resources, effective February 1, 2024.
On January 31, 2024, the Company entered into a Separation Agreement with Mr. Floroiu (the “Separation Agreement”).
Drew D. Hall was elected to the Board of Directors as the sole director of the Company.
the Board appointed Victoria Eatwell as the chief financial officer of the Company, effective as of the date of the Closing.
the Board appointed William D. Baird, III as the president and chief executive officer of the Company, effective as of the date of the Closing.
Phillip Sawarynski, who currently serves as the Company’s Vice President of Corporate Development, Treasurer, and Managing Director and Co-Lead at Trimble Ventures, will become its new Chief Financial Officer effective at the end of May 2024.
On February 1, 2024, Dave Powers announced his intention to retire from his position as Chief Executive Officer and President of Deckers Outdoor Corporation (the “Company”), effective August 1, 2024
On February 1, 2024, the Company announced that Stefano Caroti will be appointed as President and Chief Executive Officer, effective August 1, 2024.
Effective as of February 1, 2024, the Restructuring Committee of the Boards of Directors of the Debtors (which has been vested with the full power and authority of the Boards of Directors of the Debtors with respect to certain activities related to the Debtors’ Chapter 11 Cases) approved that Mr. Pugh, in his capacity as the Debtors’ Chief Transformation Officer, shall assume all of the responsibilities, and the authority to act on behalf of the Debtors, of the Debtors’ acting Chief Financial Officer until a permanent Chief Financial Officer is appointed
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.